Clinical Trial: Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study

Brief Summary: First-line tocilizumab treatment during 6 months could permit rapid steroid-tapering and induction of remission in Takayasu arteritis (TA).